Literature DB >> 20143965

Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.

A E Ridout1, W Yoong.   

Abstract

Overactive bladder syndrome is defined as a symptom syndrome which includes urinary urgency, with or without urge incontinence, usually accompanied by frequency (>8 micturitions/24 h) and nocturia. Conservative treatment usually comprises behavioural techniques, bladder retraining, pelvic floor re-education and pharmacotherapy but up to 30% of patients will remain refractory to treatment. Although second-line treatment options such as sacral nerve stimulation and intravesical botulinum A injections are valuable additions to the therapeutic arsenal, they are relatively invasive and can have serious side-effects. Inhibition of detrusor activity by peripheral neuromodulation of the posterior tibial nerve was first described in 1983, with recent authors further confirming a 60-80% positive response rate. This review was undertaken to examine published literature on percutaneous tibial nerve stimulation and to discuss outcome measures, maintenance therapy and prognostic factors of this technique.

Entities:  

Mesh:

Year:  2010        PMID: 20143965     DOI: 10.3109/01443610903428922

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  8 in total

1.  Tibial sensory neuropathy as a rare complication of percutaneous tibial nerve stimulation.

Authors:  Di Zhou; Andreas Seraphim; Wai Yoong
Journal:  Int Urogynecol J       Date:  2014-11-19       Impact factor: 2.894

2.  2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association.

Authors:  Mathieu Bettez; Le Mai Tu; Kevin Carlson; Jacques Corcos; Jerzy Gajewski; Martine Jolivet; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

3.  Comparison of transcutaneous electrical tibial nerve stimulation for the treatment of overactive bladder: a multi-arm randomized controlled trial with blinded assessment.

Authors:  Munick Linhares Pierre; Beatriz Friso; Raquel Aparecida Casarotto; Jorge Milhem Haddad; Edmund Chada Baracat; Elizabeth Alves Gonçalves Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2021-08-16       Impact factor: 2.365

4.  Urologic agents for treatment of bladder dysfunction in neurologic disease.

Authors:  Eliza Lamin; Ariana L Smith
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

Review 5.  Overactive Bladder Syndrome: Evaluation and Management.

Authors:  Elad Leron; Adi Y Weintraub; Salvatore A Mastrolia; Polina Schwarzman
Journal:  Curr Urol       Date:  2018-02-20

6.  Neuromodulation for functional bladder disorders in patients with multiple sclerosis.

Authors:  Mohammad Sajjad Rahnama'i
Journal:  Mult Scler       Date:  2019-12-09       Impact factor: 6.312

7.  Peroneal Electric Transcutaneous NeuroModulation (eTNM®): A Novel Method for the Treatment of the Overactive Bladder.

Authors:  Jan Krhut; Lukas Peter; Michal Rejchrt; Martin Slovak; Barbora Skugarevska; Peter Zvara
Journal:  J Healthc Eng       Date:  2021-10-06       Impact factor: 2.682

Review 8.  Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Authors:  Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-23       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.